Pathalys raised $105M in a Series B round led by TCGX to support clinical trials and advance SHPT drug approval.
Amount Raised
$105 Million
Round Type
Series B
RaleighBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Pathalys Pharma has secured $105M in a Series B financing round to support its clinical trials, file a new drug application (NDA) with the FDA, and accelerate preapproval commercialization preparations. This funding will help advance their lead candidate, upacicalcet, towards approval.
Quick answer
Pathalys Pharma raised $105 Million in a Series B round, dated August 21, 2024. Investors: Da Vita Venture Group, Catalys Pacific, JPS Growth Investment Limited Partnership, KB Investment, Marshall Wace, Samsara Bio Capital, Jp Morgan Life Sciences Private Capital and Tcgx. Pathalys Pharma is based in Raleigh, North Carolina, United States.
- How much did Pathalys Pharma raise?
- Pathalys Pharma raised $105 Million in a Series B round on August 21, 2024.
- Who invested in Pathalys Pharma?
- Da Vita Venture Group, Catalys Pacific, JPS Growth Investment Limited Partnership, KB Investment, Marshall Wace, Samsara Bio Capital, Jp Morgan Life Sciences Private Capital and Tcgx are named as investors in this round.
- What does Pathalys Pharma do?
- Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of ESKD.
- Where is Pathalys Pharma based and how big is it?
- Pathalys Pharma is based in Raleigh, North Carolina, United States. Fundz records about 7 employees.
- Who are the decision-makers at Pathalys Pharma?
- Fundz holds 1 contact at Pathalys Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Pathalys Pharma, and when
A new round usually means Pathalys Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pathalys Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pathalys Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pathalys Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pathalys Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPathalys Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.